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Background: We conducted unlinked cross-sectional population-based surveys in Northern Uganda before
and after antiretroviral therapy (ART) provision (including Option B+ [lifelong ART for pregnant/breast-feeding
women]) at a local primary care facility (Lira Kato Health Centre [HC]). Prior to decentralisation, people trav-
elled 56–76 km round-trip for ART; we aimed to evaluate changes in uptake of HIV-testing, ART coverage and
access to ART following decentralisation.
Methods: A total of 2124 adults in 1351 households in two parishes closest to Lira Kato HC were interviewed
using questionnaires between March and April 2013 and 2123 adults in 1229 households between January
and March 2015.
Results: Adults reporting HIV-testing in the last year increased from 1077/2124 (50.7%) to 1298/2123
(61.1%) between surveys (p<0.001). ART coverage increased from 74/136 (54.4%) self-reported HIV-positive
adults in 2013 to 108/133 (81.2%) in 2015 (p<0.001). Post-decentralisation, 47/108 (43.5%) of those on ART
were in care at Lira Kato HC (including 37 new initiations). Most of the remainder (47/61, 77%) started ART
prior to any ART provision at Lira Kato HC; the most common reason given for not accessing ART locally was
concern about drug-stock-outs (30/59, 51%).
Conclusions: HIV-testing and ART coverage increased after decentralisation combined with Option B+ roll-out.
However, patients on ART before decentralisation were reluctant to transfer to their local facility.
Keywords: Antiretroviral therapy decentralisation, HIV services, Population survey, Sub-Saharan Africa, Uganda
Introduction
Decentralisation of HIV care to get treatment close to where peo-
ple live is essential to achieve the UNAIDS target of ensuring 90%
of HIV positive individuals know their status, 90% of diagnosed
HIV positive individuals receive sustained antiretroviral therapy
(ART) and 90% of people on ART have suppressed viral load
(90-90-90) by 2020.1 The recent WHO guidelines recommend
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all individuals diagnosed with HIV should be initiated on ART at
any CD4 cell count, further emphasizing that lack of access to
CD4 cell count testing should not be a barrier to starting treat-
ment and thus simplifying the ART initiation process in remote
rural areas.2
Uganda has an estimated adult HIV prevalence of 7.3%.3
According to the Uganda Ministry of Health (MOH) semi-annual
ART report (January–June 2014), 1 211 768 adults and 193 500
children are currently living with HIV, of whom, 629 212 (51.9%)
adults and 51 302 (26.5%) children are on ART.4 If Ugandan
guidelines follow the WHO recommendation of treatment for
all, the number of people in need of ART will further increase,
reinforcing the need to decentralise care to all health facilities.
Although the estimated adult HIV prevalence in rural areas is
slightly lower than in urban areas (6.9% versus 8.4%), 82% of
the population live in rural areas,3,5 highlighting the importance
of scaling up decentralised HIV treatment and care services.
Studies evaluating decentralisation of HIV care and ART ser-
vices to primary level facilities generally show this is a suc-
cessful strategy for expanding HIV care, highlighting lower loss
to follow-up (LTFU), better adherence and improved retention
in care in comparison to secondary health facilities.6–11 Most
information on ART scale-up focuses on adults, although low-
er mortality and LTFU have also been reported with successful
ART rollout to children.12,13 Decentralisation has been shown
to be beneﬁcial especially to poorer individuals and those liv-
ing in rural areas who are less likely to access HIV testing and
treatment services due to the distance to facilities and trans-
port costs.14–16
The Lablite project investigated strategies for cost-effective
and safe roll out of HIV treatment to primary health facilities
in Uganda, Malawi and Zimbabwe in collaboration with re-
spective ministries of health.17 In Uganda, we conducted a
population survey immediately prior to decentralisation of ART
to the local primary health care facility, Lira Kato Health
Centre (HC), in Lapono sub-county in the Agago district of
Northern Uganda, a remote poor rural area, with low levels of
education where most individuals rely on farming for their
livelihoods (Supplementary Tables 1 and 2).18 HIV services
available at Lira Kato HC before decentralisation of ART were
HIV-testing and drugs for elimination of mother to child trans-
mission of HIV (EMTCT). HIV positive individuals in Lapono
sub-county were only able to access ART by travelling long dis-
tances to the district hospital (Kalongo Hospital) or to Patongo
Health Centre (56 or 76 km round trip respectively), the major-
ity on foot; despite this, 54% of adults who self-reported being
HIV positive were receiving ART, although few children were
accessing testing and treatment.18
ART for Option B+ (lifelong ART for all pregnant/breastfeeding
women) was provided at Lira Kato HC from April 2013 and gen-
eral ART for all HIV positive individuals eligible for treatment
from September 2013. In this paper, we report results of a
repeat population survey in the same area approximately 20
months after Option B+ roll out and 15 months after general
ART provision at Lira Kato HC. Objectives were to describe the
knowledge of local ART provision and to compare results with
the survey pre-decentralisation with respect to: uptake of HIV
testing in the last year; coverage of ART; and access to ART,
including choice of health care facility.
Methods
Study setting
We conducted two unlinked cross-sectional population-based
surveys in Lapono sub-county in Agago district, before and after
decentralisation of ART services to Lira Kato HC. The ﬁrst survey
was conducted between February and April 2013 (Population
Based Survey 1; PBS1).The repeat survey was conducted
between January and March 2015 (Population Based Survey 2;
PBS2).
According to the health facility structure in Uganda, Lira Kato
HC is categorized as a Health Centre III (HC III); it is headed by
a clinical ofﬁcer, serves a sub-county and provides inpatient
care, outpatient, antenatal, immunization and outreach services
and environmental health. Patongo HC is categorized as a
Health Centre IV (HC IV), is headed by a medical ofﬁcer, serves a
sub-district and additionally provides surgery, supervision of the
lower HCs, data collection and health service planning. Kalongo
Hospital is the district hospital and is headed by a senior med-
ical ofﬁcer, serves the district and additionally provides training
and supervision of staff at the lower HCs and is the main referral
facility for the district. All facilities are open seven days a week.
Both Kalongo Hospital and Patongo HC have provided ART since
2006; Lira Kato HC referred patients to Kalongo Hospital for ART
pre-decentralisation. Individuals within the catchment for Lira
Kato HC are at most 9 km and mostly less than 5 km from the
HC, whereas average distances from the sub-county to Kalongo
Hospital and Patongo HC are 28 km and 38 km respectively.
Both surveys were carried out in two of the six parishes
including approximately 20% of villages in Lapono sub-county
(Figure 1). All villages in the two parishes closest to Lira Kato
HC were included. One village was used for the pilot (excluded
from both main surveys) and 17 villages were included in the
main surveys. Every household in each village was mapped
and approached during the surveys. Community meetings
were held in collaboration with local leaders to encourage par-
ticipation of the villagers in the survey. Prior to PBS1, village
mapping was done using geographical positioning system
(GPS) technology for 14 villages and manual mapping for three
villages, with additional guidance from a village member to
locate dwellings and demarcate village boundaries within the
study area. Manual mapping to update the previous maps
from PBS1 was done prior to PBS2.
Data collection
Both surveys were carried out in the same way. Two ﬁeld
supervisors led a survey team of four members trained in data
collection and ﬂuent in Luo (the local language in Agago
District). A local village member guided an interviewer to each
household but did not remain for the interviews. The inter-
viewer returned later if household members were not at home;
up to two visits were made to each household. Questionnaires
were used to collect socioeconomic data and information on
children from the household head (PBS1 and PBS2 Household
questionnaires, Supplementary Information) and individual
demographic and health-related information from up to three
adults aged 15–59 years in each household (PBS1 and PBS2
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Individual questionnaires, Supplementary information) (in a
small number of households more than three adults were
interviewed [Table 1]; all data were included in the analysis).
Individual health-related information on HIV-testing, HIV-
status and, for HIV-positive individuals, information on HIV
care and treatment was included. Minor amendments were
made to the questionnaires prior to PBS2, to capture knowl-
edge of availability of ART at Lira Kato HC and reasons for not
accessing ART at Lira Kato HC, where applicable. Interviews
were held with 2124 adults from 1351 households in PBS1
and 2123 adults from 1229 households in PBS2 (Table 1).
Respondents were not linked between surveys but household
identiﬁer numbers were maintained; 747/1401 (53.3%) of
households with a completed household questionnaire in
PBS1 completed the household questionnaire in PBS2.
Statistical analysis
We used descriptive statistics for most analyses. In line with
study objectives we evaluated differences between pre- and
post-decentralisation surveys in self-reported HIV testing in the
last year, EMTCT coverage and uptake of ART. We also investi-
gated any changes in the proportions attending Lira Kato HC for
HIV testing and for antenatal care (ANC). Villages 17, 18 and 19
were grouped as the villages furthest from Lira Kato HC and
Figure 1. Map of Lapono sub-county. Patongo Health Centre is off the map to the bottom left-hand corner.
International Health
93
closest to Kalongo hospital (Figure 1); we describe ART uptake in
these villages versus the remainder. Differences were tested
using random effects logit models including a random effect for
village. All data were analysed using Stata 12.1 (StataCorp LP,
College Station, TX, USA).
Ethics
Approval for the study protocol was obtained from the Joint
Clinical Research Centre/Research Ethical Committee (JCRC/
REC) and from the Uganda National Council for Science and
Technology (UNCST) and Ofﬁce of the President of the Republic
of Uganda. All study participants provided written informed
consent. The interviews were conducted within the household
of the participants with one participant being interviewed at a
time. Interviewers sought a private space for each interview in
the home or surrounding compound.
Results
Study participants
In PBS2, 2123 individuals were interviewed including 821
(38.7%) males and 1302 (61.3%) females; numbers were simi-
lar in PBS1 (755/2124, 35.5% males and 1369/2124, 64.5%
females). Household socio-economic indicators and partici-
pants’ individual characteristics were similar in both surveys
(Supplementary Tables 1 and 2).
Table 1. Summary of households approached during the surveys
Number of households PBS1 PBS2
Total households mapped 1895 1964
Household questionnaire completed 1401 (73.9%) 1316 (67.0%)
≥1 adult individual questionnaire completed 1351 (71.3%) 1229 (62.6%)
1 adult interviewed 753 558
2 adults interviewed 454 494
3 adults interviewed 116 138
>3 adults intervieweda 28 39
PBS1: Population-based Survey 1 (before decentralisation); PBS2: Population-based Survey 2 (after decentralisation).
a The protocol allowed to interview up to three adults per household, although all interviews were included in analysis.
Table 2. Self-reported HIV testing and self-reported HIV prevalence
Men Women Total Test for
difference (p)
PBS1
n=755
PBS2
n=821
PBS1
n=1369
PBS2
n=1302
PBS1
n=2124
PBS2
n=2123
HIV testing in the last year
Tested ≥once in the last year 406 (53.8%) 584 (71.1%) 671 (49.0%) 714 (54.8%) 1077 (50.7%) 1298 (61.1%) <0.001c
Most recent HIV test facilitya
Lira Kato Health Centre 150 (36.9%) 351 (60.1%) 207 (30.8%) 345 (48.3%) 357 (33.1%) 696 (53.6%) <0.001d
Kalongo Hospital 119 (29.3%) 124 (21.2%) 83 (12.4%) 80 (11.2%) 202 (18.8%) 204 (15.7%)
Other facilities 137 (33.7%) 109 (18.7%) 381 (56.8%) 289 (40.5%) 518 (48.1%) 398 (30.7%)
HIV prevalencea 5 (1.2%) 9 (1.5%) 31 (4.6%) 12 (1.7%) 36 (3.3%) 21 (1.6%) 0.007c
HIV testing ever
Ever tested 574 (76.0%) 734 (89.4%) 1156 (84.4%) 1173 (90.1%) 1730 (81.5%) 1907 (89.8%) <0.001c
HIV prevalenceb 34 (5.9%) 39 (5.3%) 102 (8.8%) 94 (8.0%) 136 (7.9%) 133 (7.0%) 0.30c
PBS1: Population-based Survey 1 (before decentralisation); PBS2: Population-based Survey 2 (after decentralisation).
a Restricted to those who tested in the last 12 months.
b Self-reported prevalence in those ever tested for HIV.
c PBS1 versus PBS2 across total.
d Lira Kato HC versus Kalongo and other health facilities.
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Knowledge of ART provision at nearest health facility
in PBS2
After introduction of ART provision at Lira Kato HC, 1454/2107
(69.0%) participants reported Lira Kato HC as the nearest health
facility with ART provision; 618/2107 (29.3%) still thought
Kalongo hospital was the nearest ART facility. Knowledge of ART
provision at Lira Kato HC depended on village location; 324/771
(42.0%) participants in the three villages furthest from Lira Kato
HC reported ART was available there (with most reporting
Kalongo Hospital as the nearest facility with ART) compared
with 1130/1336 (84.6%) in the 13 villages closer to the HC.
Knowledge of ART provision at Lira Kato HC did not vary by age,
sex or education (data not shown), and was mostly acquired
from friends/relatives (640/1452 [44.1%]) or through attend-
ance at Lira Kato HC for other services (432/1452 [29.8%]),
while 148/1452 (10.2%) heard about it through community
talks (n=2 missing data).
HIV testing in last 12 months and HIV prevalence
The proportion of people who reported testing for HIV at least
once in the last year had increased from 1077/2124 (50.7%) in
2013 to 1298/2123 (61.1%) in 2015 (p<0.001), with increases
seen in men and women (Table 2, Figure 2). Among those who
tested in the last year, most recent HIV tests were more likely to
be at Lira Kato HC in PBS2 than in PBS1; HIV tests at Lira Kato
HC in the past year increased nearly twofold between surveys
from 357/2124 (16.8%) in PBS1 to 696/2123 (32.8%) partici-
pants in PBS2 (Table 2, Figure 2). Self-reported HIV prevalence in
individuals ever-tested was similar in both surveys (136/1730
[7.9%] in PBS1; 133/1907 [7.0%] in PBS2); prevalence was lower
in individuals who had tested in the last year in PBS2 (21/1298
[1.6%]) than in PBS1 (36/1077 [3.3%]) (p=0.007).
ANC and EMTCT
At the time of PBS1, rates of attendance at antenatal care dur-
ing pregnancy and HIV-testing during pregnancy were both
high.18 Similarly, in PBS2, 576/579 (99.5%) women who had
given birth in the two years preceding the survey attended ante-
natal care; 15/576 (2.6%) were already diagnosed with HIV
(including eight on ART). Of the remainder, 558/561 (99.5%)
reported testing for HIV and 13/561 (2.3%) tested positive; 14/
15 (93%) women diagnosed pre-pregnancy and 12/13 (92%)
women newly diagnosed in antenatal care reported receiving
ART for themselves to prevent transmission to their baby.
Although not statistically signiﬁcant, ART coverage in newly
diagnosed women was higher than in PBS1 (12/13 [92%] vs 15/
23 [65%]; p=0.12). HIV-positive women who gave birth in the
two years prior to survey were marginally more likely to attend
Lira Kato HC for antenatal care in PBS2 (19/28 [68%]) than in
PBS1 (12/27 [44%]) (p=0.10).
HIV care and treatment in adults
Most HIV-positive adults with self-reported HIV diagnosis
(including those diagnosed through antenatal care) were in HIV-
care in both surveys (124/136 [91.2%] in PBS1; 125/133 [94.0%]
in PBS2). At the time of PBS1, 74/136 (54.4%) individuals were
on ART compared with 108/133 (81.2%) in PBS2 (p<0.001). The
proportion of men on ART increased from 20/34 (59%) to 27/39
(69%) (p=0.17) and women on ART increased from 54/102
(52.9%) to 81/94 (86%) (p<0.001). Very few individuals had
taken ART in the past but were not currently on ART (seven in
PBS1, one in PBS2). Sixteen of 81 (20%) of women on ART at the
time of PBS2 initiated ART post Option B+ roll-out either during
pregnancy or within one year of giving birth; without Option B+
(assuming none of these women would have otherwise started
ART), ART coverage would have reached 92/133 (69.2%) (com-
pared to 74/136 [54.4%] in PBS1, p=0.003).
During PBS1, 69/74 (93%) adults on ART received care either
at Kalongo Hospital or Patongo HC (average 56 km and 76 km
round trip from Lapono sub-county respectively); the remainder
were being seen elsewhere (three people) or the information
was missing (two people).18 HIV-positive individuals living in the
three villages closest to Kalongo Hospital (villages 17, 18, 19
[Figure 1]) were more likely to be on ART than those living fur-
ther away (44/63 [70%] vs 30/73 [41%]; p=0.001). Post-
decentralisation, 47/108 (43.5%) of those on ART were in care
at Lira Kato HC, 58/108 (53.7%) were in care either at Kalongo
Hospital (n=55) or Patongo HC (n=3) and the remaining 3/108
(2.8%) were at other facilities (Table 3, Figure 3). In PBS2, pro-
portions of HIV-positive individuals on ART were similar in the
three villages closest to Kalongo Hospital and the remainder
(33/41 [80%] vs 75/92 [82%]; p=0.89). All individuals receiving
ART at Lira Kato HC went there on foot. The median self-
reported time taken for an individual to travel to Lira Kato HC,
receive ART and return home was 5 h (3–6 h); this was
0%
20%
40%
60%
80%
100%
PBS1 PBS2 PBS1 PBS2
Males Females
Not tested in last 12 months 
Tested in last 12 months with most recent test at:
Other test facilityKalongo hospitalLira Kato HC
Proportion of survey participants
Figure 2. Self-reported HIV testing in the last 12 months and most
recent test facility before and after antiretroviral therapy (ART) provision
at the local primary care facility (Lira Kato Health Centre). PBS1:
Population-based Survey 1 (before decentralisation); PBS2: Population-
based Survey 2 (after decentralisation).
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substantially less than time taken to access ART across all facil-
ities in PBS1 (12 h [10–24 h]).
When interviewed for PBS2, only 5/52 (10%) individuals who
started ART prior to April 2013 were receiving ART at Lira Kato
HC, having transferred there post ART initiation, whereas 6/9
(67%) individuals who started ART between April and August
2013 (including four initiations at Lira Kato [all for Option B+]
and two transfers) and 36/47 (77%) individuals who started ART
from September 2013 onwards (33 initiations, three transfers)
were receiving ART at Lira Kato HC (Table 3, Figure 3).
In total, only 10/71 (seven from Kalongo Hospital, two from
Patongo HC and one from another facility) patients who started
ART elsewhere had transferred to Lira Kato HC for ART (Table 3).
The primary reasons given by 59/61 individuals for not accessing
ART at Lira Kato HC included concerns about drug stock-outs
(30/59 [51%]), starting ART before ART availability at Lira Kato
HC (13/59 [22%]), lack of trust in clinical staff at Lira Kato HC (5/
59 [8%]), stigma (4/59 [7%]) and others reasons (7/59 [12%]);
all 61 knew Lira Kato HC provided ART.
Of the 37 individuals who initiated ART at Lira Kato HC, 10
(27%) were men, 14 (38%) were women initiating for Option B+
and 13 (35%) were non-B+ women. Excluding Option B+
women, 11/23 (48%) initiations were in individuals who tested
HIV-positive prior to any ART provision at Lira Kato HC.
During PBS2, 3/47 individuals on ART at Lira Kato HC reported
not being able to collect both ART and cotrimoxazole in the past
year (one individual reported 2 occasions); reasons given were
drugs out of stock (n=2) and no healthcare worker available
(n=1). One of 55 individuals on ART at Kalongo Hospital had not
been able to collect either drug because the clinic was closed;
there were no other difﬁculties reported with drug collection at
the clinic at Kalongo Hospital or the other secondary health
facilities (test for difference [Lira Kato HC vs other facilities],
p=0.20). In contrast, only 1/47 ART patients at Lira Kato HC had
missed a clinic visit due to distance/cost vs 9/61 of those still
attending more distant secondary facilities (test for difference
[Lira Kato HC vs other facilities], p=0.05).
HIV care and treatment in children
In each survey, information for only eight HIV-positive children
was provided; based on household numbers, we estimate two
children were reported in both surveys. All HIV-positive children
in PBS2 were in care and receiving both cotrimoxazole and ART
in contrast to PBS1 in which 6/8 children were on cotrimoxazole,
and only 3/8 were on ART and 1/8 child had dropped out of care
due to transport costs to Kalongo Hospital (Table 4). The major-
ity of children attended Kalongo Hospital (5/7 in PBS1 and 5/8 in
PBS2). Post-decentralisation, 3/8 children on ART were in care
Table 3. Current HIV care facility by time of antiretroviral therapy (ART) initiation in adults in PBS2 (Population-based Survey 2 [after
decentralisation])
Time of ART initiation HIV care facility at time of interview
Kalongo Hospital or Patongo
Health Centre
Lira Kato Health Centre Other
Initiating facility Transfer-in Initiating facility Transfer-in Initiating facility Transfer-in
Before April 2013a 44 2 0 5 1 0
April 2013 to August 2013b 3 0 4 2 0 0
September 2013c to February 2014 3 0 12 0 1 0
March 2014 to August 2014 4 1 8 2 0 0
September 2014 to interviewd 1 0 13 1 1 0
Total 55 3 37 10 3 0
a No ART was available at Lira Kato Health Centre prior to April 2013.
b Option B+ was available at Lira Kato Health Centre.
c General ART was available at Lira Kao Health Centre from September 2013.
d Interview was conducted between January and March 2015.
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Figure 3. Current antiretroviral therapy (ART) facility at time of interview
(Population-based Survey 2 [PBS2]) after decentralisation by time of ART
initiation.
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locally at Lira Kato HC; one was a new initiation and two trans-
ferred to Lira Kato HC from another facility after starting ART.
Reasons for not accessing ART locally included fear of drug
stock-outs (2/5), not knowing ART was available at Lira Kato HC
(1/5), awaiting transfer to Lira Kato HC (1/5) and reason
unknown (1/5).
Discussion
Population-based surveys pre- and post-decentralisation of ART
alongside Option B+ roll-out at the local primary health care
facility in Agago, Northern Uganda demonstrated beneﬁts of
decentralisation including an increase in the proportion of adults
who reported testing for HIV in the last year, increased ART
coverage and 44% of adults on ART accessing HIV care locally.
The increase in recent HIV testing was driven by additional test-
ing at the primary health care facility, particularly in men, which
suggests that the availability of ART locally may have been a
catalyst for the population seeking HIV testing; the safe male
circumcision programme has run in the district for four years,
covered both survey periods, and is likely to have contributed to
the high levels of testing in men noted in both surveys. We
did not collect information on reasons for recent HIV-testing
which would have aided the understanding of these results.
Encouragingly, although overall HIV prevalence was similar,
among those tested in the last year, the proportion of self-
reported positive tests declined between surveys. There was a
signiﬁcant increase in overall ART coverage, with a likely increase
in EMTCT coverage; although undoubtedly, these increases were
partly due to a change in HIV treatment guidelines which raised
the CD4 threshold for ART initiation from 350 to 500 cell count,
as well as country-wide roll-out of the Option B+ pro-
gramme.19,20 Post-decentralisation new ART initiations were
predominantly at the primary care facility, suggesting over time
a higher proportion of ART patients will be treated locally.
Around half of non-option B+ initiations at the primary care
facility were in patients who had tested positive before any ART
provision was available there hence some individuals may have
been eligible for treatment previously but unable to receive it.
The majority of patients who had started ART in secondary
care prior to decentralisation of ART locally were reluctant to
transfer to the primary care facility, despite the long distances
they were travelling for treatment. A study conducted in
Tanzania found that some patients preferred to attend more
established health facilities rather than seeking care at the clos-
est HIV care facilities.21 A study on patient attitudes towards
decentralisation at an urban clinic in South Africa, showed some
patients had reservations about receiving ART close to where
they live due to concerns about stigma, lack of conﬁdentiality,
untrained staff and poor relations with nurses.22 However, in
this study, fear of drug stock-outs was given by around half of
the HIV-positive individuals as the reason for not transferring to
the primary care facility for follow-up. Most of the remainder
cited already starting ART elsewhere; it was unclear whether
these individuals were unwilling to move, had not considered
transferring, or were encouraged to remain at their current cen-
tre; all were aware of local availability of ART. Notably few indivi-
duals cited stigma and this did not appear to be a major
concern among individuals on ART in this particular rural loca-
tion. However, this study cannot address whether or not stigma
remains a problem for individuals who had not been tested for
HIV or did not reveal their HIV diagnosis during interview.
Engaging staff at the secondary care facility (Kalongo Hospital)
to encourage and promote transfer of individuals on ART from
Lapono sub-county is one of the strategies being used to
improve transfer of clients on ART to their local primary care
facility. In addition community linkage facilitators and village
health teams continue to emphasize the availability of compre-
hensive HIV care and treatment services locally during home
visits; in the light of our results these activities may require
strengthening.
A small number of patients reported problems collecting
drugs due to stock-outs at the primary care facility but no issues
were reported in secondary care facilities, reinforcing the need
for stock management training for staff especially at primary
level facilities to ensure timely ordering and correct projection of
HIV commodities. However, patients were more likely to miss
attending clinic at secondary facilities than at the primary care
facility due to distance and cost.
The numbers of children in care still appeared low, even after
decentralisation of ART to the local primary care facility. Given
high EMTCT coverage, it may be that few new infant infections
now occur. It is unclear to what extent older HIV-infected chil-
dren are still outside HIV care; although guidelines include
Table 4. Summary of the children with HIV children reported in
both surveys
Surveys PBS1
n=8
PBS2
n=8
Current age
<2 0 0
2–5 4 3
>5 4 5
Current health facility
Lira Kato Health Centre 2 3
Kalongo Hospital 5 5
Not in care 1 0
Currently on cotrimoxazole 6 8
Currently on ART 3 8
Transport to health facility
Own bike 1 3
Borrowed bike 1 2
Foot 5 3
Primary carer
Mother 5 6
Father 1 1
Grandmother 1 0
Siblings 1 0
Uncle 0 1
ART: antiretroviral therapy; PBS1: Population-based Survey 1 (before
decentralisation); PBS2: Population-based Survey 2 (after
decentralisation).
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provider-initiated counselling and testing, in practice this is
often missed.23 Although numbers were small, the majority of
the children in care attended Kalongo Hospital for ART, and
some carers cited fear of drug stock-outs as the reason for not
accessing ART locally; previous work has suggested that stock-
outs of paediatric ART may be more frequent than of adult
ART.24
Post-decentralisation, over two-thirds of the population
reported the local primary care facility as the nearest facility
where one could receive ART, although fewer participants were
aware of local ART availability in the villages furthest from the
health facility, suggesting community engagement could still be
improved.
One of the limitations of the study was that we were unable
to link individuals between surveys so our conclusions are lim-
ited to cross-sectional comparisons. Given there was substantial
overlap between participating households, and must have been
considerable overlap between individuals, we may have under-
estimated changes between surveys. Another limitation was
that all information collected relied on self-report and we had
no linked data from health facilities to verify participants’
responses; in particular, we had no HIV-testing data thus we
may have underestimated HIV prevalence. However, prior to the
survey, the team of interviewers had residential training focus-
ing on conducting community HIV surveys, including role play
sessions on how to encourage accurate self-reporting of HIV
status among respondents. There is evidence that response bias
can be minimized by training interviewers to act ethically, build
rapport and probe responses for more valid answers.25 Lastly,
we included all households in the two parishes closest to the
local health centre; whilst this means that we interviewed indivi-
duals most likely to beneﬁt from decentralisation of ART services
this could be a limitation of our ﬁndings if use of health services
differs in populations living further away.
Conclusion
HIV-testing and ART coverage, increased after decentralisation
combined with Option B+ roll-out. Individuals starting ART
mostly started locally. Patients who started ART prior to decen-
tralisation were however reluctant to transfer to their local facil-
ity; the majority feared drug stock-outs. Although we identiﬁed
only a low level of experience of stock-outs, the emphasis on
stock management training for staff especially at primary level
facilities to ensure timely ordering and correct projection for HIV
commodities is critical. Patients attending secondary facilities
were more likely to miss collecting ART due to distance/cost
therefore reinforcing the need for decentralising ART services
close to home.
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